LY2090314
CAS: 603288-22-8
Ref. TM-T1755
| 1mg | 48.00 € | ||
| 2mg | 62.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 260.00 € | ||
| 50mg | 423.00 € | ||
| 100mg | 624.00 € | ||
| 1ml*10 (DMSO) | 106.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Product Information
Name:
LY2090314
Synonyms:
- LY-2090314
CAS:
Description:
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
512.53
Formula:
C28H25FN6O3
Purity:
99.88%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1755 LY2090314
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
